AI Verdict
SAIC has stronger fundamentals based on our AI analysis.
SANA vs SAIC Fundamental Comparison
| Metric | SANA | SAIC |
|---|---|---|
| Revenue | N/A | $7.3B |
| Net Income | $-244.2M | $358.0M |
| Net Margin | N/A | 4.9% |
| ROE | -151.8% | 23.9% |
| ROA | -58.6% | 6.7% |
| Current Ratio | 1.89x | 1.20x |
| Debt/Equity | 0.00x | 1.66x |
| EPS | $-0.96 | $7.70 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
SANA vs SAIC: Frequently Asked Questions
Is SANA or SAIC a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), SAIC has stronger fundamentals. SANA is rated SELL (72% confidence) while SAIC is rated HOLD (72% confidence). This is not investment advice.
How does SANA compare to SAIC fundamentally?
Sana Biotechnology, Inc. has ROE of -151.8% vs Science Applications International Corp's 23.9%. Net margins are N/A vs 4.9% respectively.
Which stock pays higher dividends, SANA or SAIC?
SANA has a dividend yield of N/A or no dividend while SAIC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in SANA or SAIC for long term?
For long-term investing, consider that SANA has SELL rating with 72% confidence, while SAIC has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about SANA vs SAIC?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For SANA vs SAIC, the AI consensus favors SAIC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.